摘要
Positron emission computed tomography (PET) is a functional, noninvasive method for imaging regional metabolic processes that is nowadays most often combined to morphological imaging with computed tomography (CT). Its use is based on the well-founded assumption that metabolic changes occur earlier in tumors than morphologic changes, adding another dimension to imaging. This article will review the established and investigational indications and radiopharmaceuticals for PET/CT imaging for prostate cancer, bladder cancer and testicular cancer, before presenting upcoming applications in radiation therapy.
学科与关键词
关键词
Prostate cancerbladder cancertesticular cancerpositron emission tomographyF-18-fluorodeoxyglucose
- Value of positron emission tomography and computer tomography (PET/CT) for urologic malignanciesBoujelbene, N.; Prior, J. O.; Boubaker, A.; Azria, D.; Schaffer, M.; Gez, E.; Jichlinski, P.; Meuwly, J-Y; Mirimanoff, R. O.; Ozsahin, M.; Zouhair, A.*Cancer Radiotherapie, 2011, 15(4): 307-315.被引 3
- The Role of PET-CT Imaging in Prostate CancerSubesinghe, Manil*; Kulkarni, Meghana; Cook, Gary J.SEMINARS IN ULTRASOUND CT AND MRI, 2020, 41(4): 373-391.被引 2
- PET Imaging in Bladder Cancer: An Update and Future DirectionZhang-Yin, Jules*; Girard, Antoine; Marchal, Etienne; Lebret, Thierry; Homo Seban, Marie; Uhl, Marine; Bertaux, MarcPharmaceuticals, 2023, 16(4): 606.被引 5
